SCHEMBL3518299

SCHEMBL3518299

CCCOc1ccccc1-c1cnc2c(C(=O)NCC(=O)O)c(O)ccc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN3 Q9H6Z9 3/20 0.49
ABL1 P00519 1/20 0.41
FTO Q9C0B1 4/20 0.40
EGLN1 Q9GZT9 4/20 0.40
KDM5B Q9UGL1 3/20 0.40
KDM2A Q9Y2K7 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM6B O15054 2/20 0.40
HIF1A Q16665 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
KDM3A Q9Y4C1 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
PDE5A O76074 5/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3520489 0.89 EGLN3 (0.52) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3518292 0.87 EGLN3 (0.49) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3757200 0.85 EGLN3 (0.57) EGLN3FTOEGLN1KDM5BKDM2A
SCHEMBL3518484 0.83 EGLN3 (0.47) EGLN3FTOEGLN1KDM5BKDM2A
SCHEMBL3523500 0.83 EGLN3 (0.48) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3519422 0.82 EGLN3 (0.53) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3518710 0.82 EGLN3 (0.54) EGLN3FTOEGLN1KDM5BKDM2A
SCHEMBL3521806 0.82 EGLN3 (0.52) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3522327 0.82 EGLN3 (0.52) EGLN3ABL1FTOEGLN1KDM5B
SCHEMBL3520319 0.81 EGLN3 (0.55) EGLN3FTOEGLN1KDM5BKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP claimed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO claimed